Radiographic and Clinical Outcomes of Periprosthetic Distal Femur Fractures Treated With Open Reduction Internal Fixation

2018 ◽  
Vol 32 (10) ◽  
pp. 515-520 ◽  
Author(s):  
Alexander B. Christ ◽  
Harshvardhan Chawla ◽  
Elizabeth B. Gausden ◽  
Jordan C. Villa ◽  
David S. Wellman ◽  
...  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Harsh Wadhwa ◽  
Brett P. Salazar ◽  
L. Henry Goodnough ◽  
Noelle L Van Rysselberghe ◽  
Malcolm R. DeBaun ◽  
...  

2020 ◽  
Author(s):  
Junzhe Zhang ◽  
Junyong Li ◽  
Kuo Zhao ◽  
Hongyu Meng ◽  
Yanbin Zhu ◽  
...  

Abstract Background: There remain limited data on the epidemiological characteristics and related predictors of surgical site infection (SSI) after open reduction and internal fixation (ORIF) for distal femur fractures. We designed this single-centre prospective study to explore and resolve these clinical problems.Methods:From October 2014 to December 2018, 364 patients with distal femur fractures were treated with ORIF and followed for complete data within one year. Receiver operating characteristic (ROC) analyses, univariate Chi-square analyses, and multiple logistic regression analyses were used to screen the adjusted predictors of SSI.Results: The incidence of SSI was 6% (22/364): 2.4% for superficial SSIs and 3.6% for deep SSIs. Staphylococcus aureus (methicillin-resistant S. aureus in 2 cases) was the most common pathogenic bacteria (7, 36.8%). In multivariate analysis, parameters independently associated with SSI were: Open fracture (OR: 7.27, p = 0.003), drain use (OR: 4.11, p = 0.037), and incision cleanliness (OR: 3.53, p = 0.002). An albumin/globulin (A/G) level ≥ 1.35 (OR: 0.23, p = 0.042) was an adjusted protective factor for SSI. Conclusions: The SSI after ORIF affected approximately one in 15 patients with distal femur fractures. We recommend that maintaining A/G levels higher than 1.35 is introduced during hospitalization and elaborative evaluation of drain use is conducted for reducing the risk of post-operative SSI. Trial registration: NO 2014-015-1, October 15, 2014. We registered our trial prospectively in October 15, 2014 before the first participant was enrolled. This study protocol was conducted according to the Declaration of Helsinki and approved by the Institutional Review Board. The ethics committee approved the Surgical Site Infection in Orthopaedic Surgery (NO 2014-015-1). Data used in this study were obtained from the patients who underwent orthopaedic surgeries between October 2014 to December 2018. Keywords : predictor, surgical site infection, distal femoral fracture, internal fixation surgery


Sign in / Sign up

Export Citation Format

Share Document